FDA orphan drug grants
Agency announced in the Jan. 10 Federal Register that it anticipates availability of funds in FY 1986 for 20-30 grants ranging from $20,000 to $70,000 for orphan product clinical trials. Applications must be received by March 11. The earliest beginning date for awards is August 1. Applications should be obtained from and submitted to Kathryn McKnight, State Contracts and Assistance Agreements Branch (HFA-520), FDA, Room 15A-17, 5600 Fishers Lane, Rockville, MD 20857, 301/443-6170.
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.